Is CBD a better option than NSAIDs?October 2, 2023CBD has amassed evidential support and transparent quality control. Could it provide a suitable treatment choice? Certainly, more remains to be known about dosing and drug-herb interactions.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Nixing 'compounded' medication problemsSeptember 18, 2023With the growth of 503B-manufactured veterinary drugs, there has been an increase in the number of compounded medications available in a range of “standard” dosage offerings appropriate for animal use.
What to question about supplementsAugust 31, 2023In 2020, the global veterinary dietary supplements market size swelled to $1.6 billion. The top conditions targeted for animals include joint health, liver health, immune function, and digestion.
Canine dermatitis chewable med gets FDA approvalJune 23, 2023Zoetis’ Apoquel Chewable can be administered to dogs at least 12 months of age for the control of atopic dermatitis and pruritus associated with allergic dermatitis
Do you know how to handle drug disposal?May 25, 2023How many of you have outdated drugs within your hospitals? Have you poured an expired bottle of a liquid medication into a kitty litter to dispose of it? Or maybe just dumped them in the garbage?
Pour-on NSAID for mastitis-induced fever in cattle OKed by FDAFebruary 22, 2023Merck Animal Health receives U.S. Food and Drug Administration (FDA) approval of expanded indication for BANAMINE TRANSDERMAL for the control of fever in cattle due to mastitis
Practicing antimicrobial stewardshipFebruary 1, 2023 Antimicrobial stewardship (AMS), particularly as related to antimicrobial resistance (AMR), should be considered daily due to its global prioritization by the World Health Organization (WHO) and other human and veterinary key groups.
FDA updates compounding guidelines for vetsDecember 7, 2022This past summer, the Food and Drug Administration (FDA) issued a new Guidance for Industry (GFI) that will take effect in April 2023, affecting how compounding pharmacies fill veterinary prescriptions. Called GFI #256, the guidance is intended to encourage the use of FDA-approved drugs by veterinary professionals and control which bulk substances are used to create compounded medications.
Veterinary efforts critical in fight against AMRJuly 8, 2022Ensuring animal health professionals understand their critical role in the fight against antimicrobial resistance (AMR) is the driving force behind a new set of recommendations, published jointly by the American Animal Hospital Association (AAHA) and the American Association of Feline Practitioners (AAFP).
The why and when to compound medicationsMarch 22, 2022Do your doctors freeze when you say, “Why don’t you have it compounded?”